3 Fashion Brands Company, Diagnostics Services Company and Wires and Cables Maker Stocks With a Strong Future Roadmap: Arvind Fashions, Metropolis Healthcare and RR Kabel
- November 12, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Arvind Fashions, Metropolis Healthcare and RR Kabel: ROE of 12.6% to 19.1% and FY22 to FY26 revenue CAGR of 7.6% to 21.9%. Prices as of 11 Nov 2026.
Quick Answer
The three apparel brand, diagnostics lab and cable stocks to watch are Arvind Fashions, Metropolis Healthcare and RR Kabel. Their return on equity ranges from 12.6% to 19.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.9%. RR Kabel leads on both return on equity at 19.1% and revenue growth at 21.9% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.
Apparel brand, diagnostics lab and cable stocks bring together companies with a visible plan for the years ahead. Arvind Fashions, Metropolis Healthcare and RR Kabel cover a fashion brands company, a diagnostics services company and a wires and cables maker.
This list covers three apparel brand, diagnostics lab and cable stocks with complete current figures: Arvind Fashions, Metropolis Healthcare and RR Kabel. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Apparel Brand, Diagnostics Lab and Cable Stocks?
Apparel brand, diagnostics lab and cable stocks are listed companies that sell apparel and accessories through well known brands and stores, run pathology and diagnostic labs with collection centres across many cities, and make wires, cables, fans and lighting for homes and industry. Their earnings depend on consumer spending, test volumes and building activity.
Apparel Brand, Diagnostics Lab and Cable Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Arvind Fashions | 349.45 | 4,847 | 26.0 | 49.5 | 13.0 | 1.42 |
| Metropolis Healthcare | 576.15 | 10,780 | 53.1 | 59.6 | 12.6 | 0.15 |
| RR Kabel | 1,948.7 | 24,189 | 39.8 | 37.5 | 19.1 | 0.13 |
On valuation, Arvind Fashions and Metropolis Healthcare trade at a P/E below the industry P/E, while RR Kabel trades above it, which reflects the growth the market already expects. Readers comparing apparel brand, diagnostics lab and cable stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in apparel brand, diagnostics lab and cable stocks can use the coming numbers to test whether growth is holding.
Why Do Apparel Brand, Diagnostics Lab and Cable Stocks Have a Strong Roadmap in India?
Apparel brand, diagnostics lab and cable stocks have a strong roadmap in India because wider reach of branded apparel, growing use of preventive health tests and heavy investment in housing and power keep widening the market for these companies.
- Apparel brands. Shoppers upgrade to branded clothing.
- Diagnostics. Doctors order more tests for early care.
- Wires and cables. Homes and grids need safe wiring.
Why Arvind Fashions Features Among These Apparel Brand, Diagnostics Lab and Cable Stocks
Among the apparel brand, diagnostics lab and cable stocks on this list, Arvind Fashions is a branded apparel and retail company that sells brands such as U.S. Polo Assn., Arrow, Flying Machine and Tommy Hilfiger through stores, department stores and online channels.
The company has a return on equity of 13.0%, a debt to equity ratio of 1.42 and a market capitalisation of Rs 4,847 crore. The stock trades at a P/E of 26.0, below the industry P/E of 49.5.
Revenue rose from Rs 3,123 crore in FY22 to Rs 5,307 crore in FY26, a compound annual growth rate of 14.2%. Net profit grew from Rs 109 crore in FY23 to Rs 185 crore in FY26, which works out to a compound annual growth rate of 19.2%. In the June 2026 quarter, revenue grew 14.6% year on year to Rs 1,286 crore, while net profit rose 11.1% to Rs 27.6 crore.
Roadmap: The company is expanding its exclusive brand stores and growing its online sales while adding new brands, which supports revenue growth. Strong licensed brands with loyal customers help repeat demand.
What to watch: Follow same-store sales, store additions and online growth.
Why Metropolis Healthcare Features Among These Apparel Brand, Diagnostics Lab and Cable Stocks
Among the clothing label, test centre and wire shares on this list, Metropolis Healthcare, headquartered in Mumbai, is a pathology and diagnostics company that runs a national network of laboratories, patient service centres and collection points, and also serves hospitals and corporate clients.
Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%.
In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P/E of 53.1, below the industry P/E of 59.6.
Roadmap: The company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.
What to watch: Follow test volumes per patient and the pace at which newer regions turn profitable.
Why RR Kabel Features Among These Apparel Brand, Diagnostics Lab and Cable Stocks
Among the three companies on this list, RR Kabel manufactures wires and cables for homes, industry and infrastructure, and it also sells electrical products such as fans, lighting and switches under its own brand.
In the June 2026 quarter, revenue grew 54.6% year on year to Rs 3,201 crore, while net profit rose 128.8% to Rs 205 crore. Revenue rose from Rs 4,432 crore in FY22 to Rs 9,779 crore in FY26, a compound annual growth rate of 21.9%.
Net profit grew from Rs 214 crore in FY22 to Rs 492 crore in FY26, which works out to a compound annual growth rate of 23.2%. The company has a return on equity of 19.1%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 24,189 crore. The stock trades at a P/E of 39.8, above the industry P/E of 37.5.
Roadmap: The company is growing its fast-moving electrical goods range and widening its dealer reach. Rising housing and infrastructure activity supports steady demand for wires and cables.
What to watch: Follow copper and aluminium costs, dealer network growth and the share of electrical goods in sales.
Arvind Fashions vs Metropolis Healthcare vs RR Kabel on Key Financials
The table below sets the three apparel brand, diagnostics lab and cable stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Arvind Fashions | 3,123 | 5,307 | 14.2% | 185 | 3.5% |
| Metropolis Healthcare | 1,246 | 1,671 | 7.6% | 191 | 11.4% |
| RR Kabel | 4,432 | 9,779 | 21.9% | 492 | 5.0% |
RR Kabel posts the highest return on equity in this group at 19.1%. RR Kabel combines the largest FY26 revenue at Rs 9,779 crore with the fastest revenue growth, a 21.9% compound annual rate. A useful habit with apparel brand, diagnostics lab and cable stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several fashion retailer, pathology chain and wires stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Arvind Fashions | 1,122 | 1,286 | 14.6% |
| Metropolis Healthcare | 394 | 455 | 15.7% |
| RR Kabel | 2,071 | 3,201 | 54.6% |
Key Risks to Check Before Investing in Apparel Brand, Diagnostics Lab and Cable Stocks
Every theme carries risks that deserve a check before any decision. For these apparel brand, diagnostics lab and cable stocks, the main points are: Long-term clothing label, test centre and wire shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Footfall and spending. Store sales follow consumer mood and seasons.
- Test volumes. Footfall and test mix can vary with seasons.
- Raw material costs. Ingredient and packaging prices can move margins.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter apparel brand, diagnostics lab and cable stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Apparel Brand, Diagnostics Lab and Cable Stocks
Apparel brand, diagnostics lab and cable stocks suit investors who prefer to study business strength before price moves. Arvind Fashions, Metropolis Healthcare and RR Kabel each have a clear plan to grow. Based on the 11 November 2026 close, Arvind Fashions trades at Rs 349.45, Metropolis Healthcare at Rs 576.15 and RR Kabel at Rs 1,948.7. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these apparel brand, diagnostics lab and cable stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track apparel brand, diagnostics lab and cable stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are apparel brand, diagnostics lab and cable stocks?
Ans. Apparel brand, diagnostics lab and cable stocks are listed companies that sell apparel and accessories through well known brands and stores, run pathology and diagnostic labs with collection centres across many cities, and make wires, cables, fans and lighting for homes and industry. Their earnings depend on consumer spending, test volumes and building activity. This list looks at three of them, Arvind Fashions, Metropolis Healthcare and RR Kabel, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.
Which apparel brand, diagnostics lab and cable stocks are covered in this list?
Ans. This list covers Arvind Fashions, Metropolis Healthcare and RR Kabel. Based on the 11 November 2026 close, Arvind Fashions traded at Rs 349.45, Metropolis Healthcare at Rs 576.15 and RR Kabel at Rs 1,948.7. Their return on equity ranges from 12.6% to 19.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.9%.
Why do apparel brand, diagnostics lab and cable stocks have a strong future roadmap in India?
Ans. Apparel brand, diagnostics lab and cable stocks have a strong roadmap in India because wider reach of branded apparel, growing use of preventive health tests and heavy investment in housing and power keep widening the market for these companies. The main drivers are as follows. Apparel brands. Shoppers upgrade to branded clothing. Diagnostics. Doctors order more tests for early care. Wires and cables. Homes and grids need safe wiring. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Arvind Fashions performed financially?
Ans. Revenue rose from Rs 3,123 crore in FY22 to Rs 5,307 crore in FY26, a compound annual growth rate of 14.2%. Net profit grew from Rs 109 crore in FY23 to Rs 185 crore in FY26, which works out to a compound annual growth rate of 19.2%. In the June 2026 quarter, revenue grew 14.6% year on year to Rs 1,286 crore, while net profit rose 11.1% to Rs 27.6 crore. The company has a return on equity of 13.0%, a debt to equity ratio of 1.42 and a market capitalisation of Rs 4,847 crore. The stock trades at a P/E of 26.0, below the industry P/E of 49.5. Looking ahead, the company is expanding its exclusive brand stores and growing its online sales while adding new brands, which supports revenue growth. Strong licensed brands with loyal customers help repeat demand.
How has Metropolis Healthcare performed financially?
Ans. Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P/E of 53.1, below the industry P/E of 59.6. Looking ahead, the company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.
How has RR Kabel performed financially?
Ans. Revenue rose from Rs 4,432 crore in FY22 to Rs 9,779 crore in FY26, a compound annual growth rate of 21.9%. Net profit grew from Rs 214 crore in FY22 to Rs 492 crore in FY26, which works out to a compound annual growth rate of 23.2%. In the June 2026 quarter, revenue grew 54.6% year on year to Rs 3,201 crore, while net profit rose 128.8% to Rs 205 crore. The company has a return on equity of 19.1%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 24,189 crore. The stock trades at a P/E of 39.8, above the industry P/E of 37.5. Looking ahead, the company is growing its fast-moving electrical goods range and widening its dealer reach. Rising housing and infrastructure activity supports steady demand for wires and cables.
What risks should investors check before buying apparel brand, diagnostics lab and cable stocks?
Ans. Investors should check a few risks before buying apparel brand, diagnostics lab and cable stocks. Footfall and spending. Store sales follow consumer mood and seasons. Test volumes. Footfall and test mix can vary with seasons. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of apparel brand, diagnostics lab and cable stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
